サイクリンユビキチネーションの制御は,Hct1がCDK調節された結合によって,アナファゼ促進複合体への結合によって行われる

W Zachariae¹, M Schwab, K Nasmyth

¹Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria.

Science (New York, N.Y.)

|November 30, 1998

まとめ

アナフェーズ促進複合体 (APC) はミトサイクリンを分解し,その過程はHct1.1によって調節される. サイクリン依存キナーゼ (CDK) はHct1を無効化し,細胞サイクル進行を制御する.

科学分野:

細胞生物学細胞生物学
分子生物学は分子生物学である.
バイオケミストリーバイオケミストリー

背景:

ミトスのサイクリンタンパク質分解は,細胞サイクル進行に不可欠である.
アナフェーズ促進複合体 (APC) は,このプロセスを調節する重要なユビキチンリガゼです.
APCの活動は,調節タンパク質とリン酸化によって厳しく制御されます.

研究の目的:

APC媒介によるミトス性サイクリン分解の調節メカニズムを解明する.
APC機能におけるHct1 (Cdh1) の役割を調査する.
細胞サイクル中のAPCとサイクリン依存キナーゼ (CDK) の相互作用を理解する.

主な方法:

タンパク質とタンパク質の相互作用を研究するための生化学的測定法.
APC複合体の組立と活動の分析.
CDKによるHct1のリン酸化研究.

主要な成果:

ミトシクリンのAPC媒介タンパク質分解は,Hct1関連性に依存している.
CDK媒介によるHct1のリン酸化は,APCとの相互作用を阻害する.
このAPCとCDKの相互抑制は,適切な細胞サイクルタイミングを保証する.

結論:

Hct1は,ミトスのサイクリン分解におけるAPCの決定的な基板特異活性化剤として作用する.
Hct1のCDKリン酸化はネガティブなフィードバックメカニズムを提供し,APCの活動を抑制します.
APCとCDKによる協調的な調節は,細胞循環の忠節性を維持するために不可欠です.

さらに関連する動画

10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

関連する概念動画

01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.

02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...

00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...